Skinstim
  • TECHNOLOGY
  • Products
  • About
    • January 2019 Amended Comprehensive Clinical Protocol
    • 2020 Clinical Study Protocol
    • 2019 Clinical Study Protocol
    • Executive Summary
    • Client Evaluation Form
    • SkinStim Patient Satisfaction Survey
    • SkinStim Expanded Enrollment Questionnaire.
    • Consumer Product
    • Template Clinical Trial Agreement
  • Related Articles
  • News
  • FAQ
  • Contact
Select Page

Leonhardt And Genovese File Patent For Bioelectric Controlled Expression Of PDGF A Powerful Organ Regeneration Cytokine

by skinstim | Feb 16, 2018 | Uncategorized

Published: Dec 20, 2016 Salt Lake City, Utah and Los Angeles, CA – December 19, 2016 (PRBUZZ) — Leonhardt’s Launchpads, an organ regeneration focused innovation/startup accelerator, focused on developing novel therapeutics for the treatment of organ...
Next Entries »

Recent Posts

  • Leonhardt’s Launchpads Accelerator To Showcase Eight Innovation Assets and Startups At 2022 Demo Day
  • Leonhardt’s Launchpads Announces Filing of Pioneering Patent for Bioelectric COL17A1 Protein Expression for Skin and Hair Regeneration
  • Leonhardt Ventures and Axolotl Biologix Announce Partnership to Study Combination Bioelectric and Biologic Therapies
  • Leonhardt Adds HIF-1 Alpha To Estate of Bioelectric Controlled Release Regenerative Proteins
  • BioLeonhardt Files Provisional Patent Application For Electrical Stimulation Controlled Release Of Follistatin

Recent Comments

    Archives

    • December 2021
    • August 2020
    • May 2018
    • February 2018

    Categories

    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    • Facebook
    • Twitter
    ©Copyright Skin-Stim.com | Website by FizzPOP Media